FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely, to surgery. Isolating the splenic and left renal veins. Performing formation of a H-shaped anastomosis between the splenic vein and the left renal vein using a synthetic prosthesis with external reinforcement, with diameter of 1/2 of the splenic vein diameter and 1.5–2 cm long by “end-to-side” type.
EFFECT: method allows to reduce the risk of bleeding, reduce the risk of venous thromboses, reduce the risk of hepatic insufficiency decompensation and the incidence of hepatopoal encephalopathy.
1 cl, 1 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING COMPLICATIONS CAUSED BY A TOTAL DISCHARGE OF BLOOD FROM THE PORTAL SYSTEM INTO THE INFERIOR VENA CAVA IN CHILDREN UNDERGOING SIDE-TO-SIDE SPLENORENAL SHUNTING OR SPLENOSUPRENAL SHUNTING FOR PORTAL HYPERTENSION | 2022 |
|
RU2789284C1 |
| METHOD FOR LAPAROSCOPIC DISTAL SPLENORENAL ANASTOMOSIS WITH SPLENIC ARTERY TYING AND STOMACH DEVASCULARIZATION IN CASE OF PORTAL HYPERTENSION | 2015 |
|
RU2624812C2 |
| SURGICAL METHOD FOR TREATING PORTAL HYPERTENSION | 1992 |
|
RU2069975C1 |
| METHOD OF TREATING PORTAL HYPERTENSION | 2011 |
|
RU2483681C2 |
| METHOD OF PORTO-CAVAL SHUNTING IN LIVER CIRRHOSIS WITH PORTAL HYPERTENSION SYNDROME | 2009 |
|
RU2410038C1 |
| METHOD OF PANCREATODUODENAL RESECTION WITH LOCALLY ADVANCED PANCREATIC CANCER AND PERIAMPULLAR REGION WITH EXTENSIVE TUMOR INVASION OF THE MAIN VEINS OF THE MESENTERIC PORTAL SYSTEM | 2017 |
|
RU2695728C2 |
| METHOD FOR DETERMINING THE RISK OF HYPERCOAGULABILITY IN PATIENTS WITH PORTAL HYPERTENSION OF CYRRHOTIC GENESIS AFTER PORTOSYSTEMIC SHUNT PLACEMENT | 2017 |
|
RU2665118C1 |
| METHOD FOR THE TREATMENT OF PATIENTS WITH LIVER CIRRHOSIS COMPLICATED BY PORTAL HYPERTENSION AND HYPERSPLENISM | 2021 |
|
RU2783657C1 |
| NON-INVASIVE METHOD FOR PRODUCING PORTAL HYPERTENSION DIAGNOSIS | 2005 |
|
RU2284755C1 |
| METHOD FOR CARRYING OUT SURGICAL TREATMENT OF PORTAL HYPERTENSION | 1992 |
|
RU2072793C1 |
